UNI-PHARMA S.A.

UNI-PHARMA
Company Profile

The Tsetis Group of Pharmaceutical Companies (OFET) is a solid reference point for the pharmaceutical and health environment, providing pioneering products placing the group’s companies amongst the most reliable ambassadors of high quality health care.

Established in 1964, UNI-PHARMA S.A.’s primary scope is the development and production of innovative, value adding products to improve the Quality of Life and is a market leader in Levothyroxine sodium, low-dose ASA and IV Paracetamol.

Established in 1996 INTERMED S.A. is specialized in high standard innovative health care products, exploring future prospects in international scientific developments, constantly expanding its product portfolio covering all major healthcare categories.

more >

Year of Establishment: 1964

Total Assets(USD):

Total Number of Staff: 500-1000

Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Production Capacity,Large Product Line,Reputation,Quality Service

Other Competitive Advantages:

Patents and Copyrights:

Send your message to this supplier
  • From:
  • To:
    UNI-PHARMA S.A.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service